Freund M - Search Results

1

Allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies after dose-escalated treosulfan/fludarabine conditioning.

Casper J, Wolff D, Knauf W, Blau IW, Ruutu T, Volin L, Wandt H, Schäfer-Eckart K, Holowiecki J, Giebel S, Aschan J, Zander AR, Kröger N, Hilgendorf I, Baumgart J, Mylius HA, Pichlmeier U, Freund M. Casper J, et al. Among authors: freund m. J Clin Oncol. 2010 Jul 10;28(20):3344-51. doi: 10.1200/JCO.2009.23.3429. Epub 2010 May 24. J Clin Oncol. 2010. PMID: 20498405

2

Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation.

Casper J, Knauf W, Kiefer T, Wolff D, Steiner B, Hammer U, Wegener R, Kleine HD, Wilhelm S, Knopp A, Hartung G, Dölken G, Freund M. Casper J, et al. Among authors: freund m. Blood. 2004 Jan 15;103(2):725-31. doi: 10.1182/blood-2002-11-3615. Epub 2003 Aug 28. Blood. 2004. PMID: 12947008 Free article. Clinical Trial.

3

Preclinical analysis of treosulfan in combination with total body irradiation as conditioning regimen prior to bone marrow transplantation in rats.

Sender V, Hofmeister-Mielke N, Sievert K, Teifke JP, Vogel H, Baumgart J, Pichlmeier U, Freund M, Casper J, Wolff D. Sender V, et al. Among authors: freund m. Immunopharmacol Immunotoxicol. 2009;31(4):595-600. doi: 10.3109/08923970902865683. Immunopharmacol Immunotoxicol. 2009. PMID: 19874228

4

Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial.

Ruutu T, Volin L, Beelen DW, Trenschel R, Finke J, Schnitzler M, Holowiecki J, Giebel S, Markiewicz M, Uharek L, Blau IW, Kienast J, Stelljes M, Larsson K, Zander AR, Gramatzki M, Repp R, Einsele H, Stuhler G, Baumgart J, Mylius HA, Pichlmeier U, Freund M, Casper J. Ruutu T, et al. Among authors: freund m. Haematologica. 2011 Sep;96(9):1344-50. doi: 10.3324/haematol.2011.043810. Epub 2011 Jun 9. Haematologica. 2011. PMID: 21659356 Free PMC article. Clinical Trial.

5

Treosulfan and fludarabine low-toxicity conditioning for allogeneic haematopoietic stem cell transplantation in chronic myeloid leukaemia.

Holowiecki J, Giebel S, Wojnar J, Krawczyk-Kulis M, Markiewicz M, Holowiecka-Goral A, Freund M, Casper J. Holowiecki J, et al. Among authors: freund m. Br J Haematol. 2008 Jun;142(2):284-92. doi: 10.1111/j.1365-2141.2008.07179.x. Epub 2008 May 19. Br J Haematol. 2008. PMID: 18492101 Free article. Clinical Trial.

6

Sirolimus in combination with tacrolimus in allogeneic stem cell transplantation--timing and conditioning regimen may be crucial.

Wolff D, Andree H, Hilgendorf I, Casper J, Freund M, Junghanss C. Wolff D, et al. Among authors: freund m. Biol Blood Marrow Transplant. 2008 Aug;14(8):942-3. doi: 10.1016/j.bbmt.2008.05.004. Biol Blood Marrow Transplant. 2008. PMID: 18640579 Free article. No abstract available.

7

Neurological complications after intrathecal liposomal cytarabine application in patients after allogeneic haematopoietic stem cell transplantation.

Hilgendorf I, Wolff D, Junghanss C, Kahl C, Leithaeuser M, Steiner B, Casper J, Freund M. Hilgendorf I, et al. Among authors: freund m. Ann Hematol. 2008 Dec;87(12):1009-12. doi: 10.1007/s00277-008-0546-0. Epub 2008 Aug 13. Ann Hematol. 2008. PMID: 18704421

8

Chronic graft versus host disease but not the intensity of conditioning has impact on survival after allogeneic hematopoietic stem cell transplantation for advanced hematological diseases.

Hilgendorf I, Wolff D, Nogai A, Kundt G, Hahn J, Holler E, Uharek L, Junghanss C, Leithäuser M, Thiel E, Freund M, Kahl C. Hilgendorf I, et al. Among authors: freund m. Onkologie. 2012;35(9):487-92. doi: 10.1159/000341835. Epub 2012 Aug 13. Onkologie. 2012. PMID: 23007145 Clinical Trial.

9

Validation of the grip test and human activity profile for evaluation of physical performance during the intermediate phase after allogeneic hematopoietic stem cell transplantation.

Kramer M, Heussner P, Herzberg PY, Andree H, Hilgendorf I, Leithaeuser M, Junghanss C, Freund M, Wolff D. Kramer M, et al. Among authors: freund m. Support Care Cancer. 2013 Apr;21(4):1121-9. doi: 10.1007/s00520-012-1634-1. Epub 2012 Nov 1. Support Care Cancer. 2013. PMID: 23111942

10

Conditioning with treosulfan and fludarabine for patients with refractory or relapsed non-Hodgkin lymphoma.

Schmitt M, Trenschel R, Sayer HG, Schneider C, Glass A, Hilgendorf I, Treschl A, Junghanss C, Borchert K, Koenigsmann M, Casper J, Beelen DW, Freund M, Kahl C. Schmitt M, et al. Among authors: freund m. Mol Clin Oncol. 2014 Sep;2(5):773-782. doi: 10.3892/mco.2014.300. Epub 2014 Jun 2. Mol Clin Oncol. 2014. PMID: 25054045 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

929 results

Search Page